The Histology of Solitary Renal Allografts at 1 and 5 Years After Transplantation

被引:110
作者
Stegall, M. D. [1 ]
Park, W. D. [1 ]
Larson, T. S. [1 ]
Gloor, J. M. [1 ]
Cornell, L. D. [1 ]
Sethi, S. [1 ]
Dean, P. G. [1 ]
Prieto, M. [1 ]
Amer, H. [1 ]
Textor, S. [1 ]
Schwab, T. [1 ]
Cosio, F. G. [1 ]
机构
[1] Mayo Clin, Div Nephrol & Hypertens, Dept Anat Pathol, von Liebig Transplant Ctr,Div Transplantat Surg, Rochester, MN 55905 USA
关键词
Fibrosis; kidney transplantation; long-term outcomes; protocol renal allograft biopsies; ACUTE REJECTION; HISTOPATHOLOGIC FINDINGS; PROTOCOL BIOPSIES; NEPHROPATHY; TACROLIMUS; NEPHROTOXICITY; CYCLOSPORINE; PROGRESSION; RISK;
D O I
10.1111/j.1600-6143.2010.03312.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Previous studies suggest that the majority of renal allografts are affected by progressive, severe chronic histologic injury, yet studies using current protocols are lacking. The goal of this study was to examine the prevalence and progression of histologic changes using protocol allograft biopsies at 1 and 5 years after solitary kidney transplantation in patients transplanted between 1998 and 2004. Chronic histologic changes generally were mild at both 1 and 5 years and were similar in deceased and living donor kidneys. The overall prevalence of moderate or severe fibrosis was 13% (60/447) at 1 year and 17% (60/343) at 5 years. In a subgroup of 296 patients who underwent both 1- and 5-year biopsies, mild fibrosis present at 1 year progressed to more severe forms at 5 years in 23% of allografts. The prevalence of moderate or severe arteriolar hyalinosis was similar in tacrolimus and calcineurin inhibitor-free immunosuppression. These results in the recent era of transplantation demonstrate fewer, less severe and less progressive chronic histologic changes in the first 5 years after transplantation than previously reported.
引用
收藏
页码:698 / 707
页数:10
相关论文
共 50 条
  • [41] Early conversion to belatacept after renal transplantation
    Nair, Vinay
    Liriano-Ward, Luz
    Kent, Rebecca
    Huprikar, Shirish
    Rana, Mena
    Florman, Sander S.
    Delaney, Veronica B.
    Menon, Madhav C.
    Sehgal, Vinita
    Miko, Leandra
    Khaim, Rafael
    Benvenisty, Alan
    Lerner, Susan
    Arvelakis, Antonios
    Wadhera, Vikram
    Ames, Scott
    Shapiro, Ron
    [J]. CLINICAL TRANSPLANTATION, 2017, 31 (05)
  • [42] Renal protection strategies after heart transplantation
    Reichart, Daniel
    Reichenspurner, Hermann
    Barten, Markus Johannes
    [J]. CLINICAL TRANSPLANTATION, 2018, 32 (01)
  • [43] Polyomavirus exerts detrimental effects on renal function in patients after lung transplantation
    Munker, Dieter
    Veit, Tobias
    Schoenermarck, Ulf
    Arnold, Paola
    Leuschner, Gabriela
    Barton, Jurgen
    Muemmler, Carlo
    Briegel, Ignaz
    Mumm, Jan-Niclas
    Zoller, Michael
    Kauke, Teresa
    Sisic, Alma
    Ghiani, Alessandro
    Walter, Julia
    Milger, Katrin
    Mueller, Susanna
    Michel, Sebastian
    Munker, Stefan
    Keppler, Oliver
    Fischereder, Michael
    Meiser, Bruno
    Behr, Juergen
    Kneidinger, Nikolaus
    Neurohr, Claus
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2021, 145
  • [44] Abatacept as rescue immunosuppression after calcineurin inhibitor treatment failure in renal transplantation
    Badell, Idelberto Raul
    Karadkhele, Geeta M.
    Vasanth, Payaswini
    Farris, Alton Brad, III
    Robertson, Jennifer M.
    Larsen, Christian P.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 (08) : 2342 - 2349
  • [45] Long-Term Outcomes Following Sirolimus Conversion after Renal Transplantation
    Soliman, Karim
    Mogadam, Emad
    Laftavi, Mark
    Patel, Sunil
    Feng, Lin
    Said, Meriem
    Pankewycz, Oleh
    [J]. IMMUNOLOGICAL INVESTIGATIONS, 2014, 43 (08) : 819 - 828
  • [46] Native Renal Arteries Denervation as a Therapy of Refractory Hypertension in Patient after Heart and Kidney Transplantation-5 Years of Observation
    Pilch, Justyna
    Mizera, Jakub
    Wisnicki, Krzysztof
    Protasiewicz, Marcin
    Kurcz, Jacek
    Zmonarski, Slawomir
    Wawrzonkowski, Patryk
    Letachowicz, Krzysztof
    Kaminska, Dorota
    Golebiowski, Tomasz
    Zakliczynski, Michal
    Krajewska, Magdalena
    Banasik, Miroslaw
    [J]. JOURNAL OF CLINICAL MEDICINE, 2023, 12 (17)
  • [47] LONG-TERM GRAFT-SURVIVAL AFTER CONVERSION FROM CYCLOSPORINE TO AZATHIOPRINE 1 YEAR AFTER RENAL-TRANSPLANTATION - A PROSPECTIVE, RANDOMIZED STUDY FROM 1 TO 6 YEARS AFTER TRANSPLANTATION
    PEDERSEN, EB
    HANSEN, HE
    KORNERUP, HJ
    MADSEN, S
    SORENSEN, AWS
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1993, 8 (03) : 250 - 254
  • [48] influence of living donor SHROOM3 and ABCB1 genetic variants on renal function after kidney transplantation
    Yan, Lin
    Li, Yi
    Tang, Jiang-Tao
    An, Yun-Fei
    Luo, Li-Mei
    Dai, Bo
    Shi, Yun-Ying
    Wang, Lan-Lan
    [J]. PHARMACOGENETICS AND GENOMICS, 2017, 27 (01) : 19 - 26
  • [49] The Kidney as a Reservoir for HIV-1 after Renal Transplantation
    Canaud, Guillaume
    Dejucq-Rainsford, Nathalie
    Avettand-Fenoel, Veronique
    Viard, Jean-Paul
    Anglicheau, Dany
    Bienaime, Frank
    Muorah, Mordi
    Galmiche, Louise
    Gribouval, Olivier
    Noel, Laure-Helene
    Satie, Anne-Pascale
    Martinez, Frank
    Sberro-Soussan, Rebecca
    Scemla, Anne
    Gubler, Marie-Claire
    Friedlander, Gerard
    Antignac, Corinne
    Timsit, Marc-Olivier
    Muda, Andrea Onetti
    Terzi, Fabiola
    Rouzioux, Christine
    Legendre, Christophe
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2014, 25 (02): : 407 - 419
  • [50] HTLV-1 associated myelopathy after renal transplantation
    Goevert, Felix
    Krumbholz, Andi
    Witt, Karsten
    Hopfner, Franziska
    Feldkamp, Thorsten
    Korn, Klaus
    Knoell, Antje
    Jansen, Olav
    Deuschl, Guenther
    Fickenscher, Helmut
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2015, 72 : 102 - 105